The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool. (2019)


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 30703670

Publication URI:

Type: Journal Article/Review

Volume: 44

Parent Publication: Breast (Edinburgh, Scotland)

ISSN: 0960-9776